专利号:US-2025206743-A1 优先权日:2022-03-25 标 题:Tyk2 inhibitor synthesis and intermediates thereof 发明人:MASSE CRAIG E; PHADKE AVINASH S; LAWSON JON P; LEVY STUART; YANG XIAOWEI; WU GUISHENG; FAN SHUFENG 权利人:TAKEDA PHARMACEUTICALS CO 摘要:Described herein are methods of synthesis of a tyrosine-protein kinase 2 (TYK2) inhibitor and to intermediate compounds of the synthesis and methods of making the intermediates. Also provided are pharmaceutically acceptable compositions including compounds prepared by the synthetic method and methods of treating disorders using the same.
专利号:CN-118922420-A 优先权日:2022-03-25 标题 :Synthesis of TYK2 inhibitors and their intermediates
专利号:US-2008096868-A1 优先权日:2004-11-12 标题:1,4 Substituted Pyrazolopyrimidines as Kinase Inhibitors 发明人:SCHMIEDEBERG NIKO; FURET PASCAL; IMBACH PATRICIA; HOLZER PHILIPP 权利人:SCHMIEDEBERG NIKO; FURET PASCAL; IMBACH PATRICIA; HOLZER PHILIPP 摘要:The invention relates to 1,4-substituted pyrazolopyrimidine compounds of the formula I, n npharmaceuticals comprising a 1,4-substituted pyrazolopyrimidine compound, the use of a 1,4-substituted pyrazolopyrimidine compound in the treatment or the use thereof in the manufacture of a pharmaceutical formulation for the treatment of a disease that depends on inadequate activity of a protein kinase, methods of treatment comprising administering a 1,4-substituted pyrazolopyrimidine compound, methods for the manufacture of a novel compound of that class, and novel intermediates and partial steps for their synthesis.
专利号:US-2008096883-A1 优先权日:2004-08-11 标题 :Trifluoromethyl substituted benzamides as kinase inhibitors 发明人:CARAVATTI GIORGIO; FURET PASCAL; IMBACH PATRICIA; MARTINY-BARON GEORG; PEREZ LAWRENCE BLAS; SHENG TAO 权利人:CARAVATTI GIORGIO; FURET PASCAL; IMBACH PATRICIA; MARTINY-BARON GEORG; PEREZ LAWRENCE BLAS; SHENG TAO 摘要:The invention relates to trifluoromethyl substituted benzamide compounds of the formula (I), pharmaceuticals comprising these compounds, their use as or for the manufacture of pharmaceuticals, particularly as inhibitors of protein kinases and/or the treatment of a condition, disorder or disease state mediated by a protein kinase activity and/or a proliferative disease, methods of treatment comprising administering the compounds, especially of therapeutic and prophylactic treatment, methods for the manufacture of the compounds and novel intermediates and partial steps for their synthesis.
摘要:Sakai C, Murotani N. [Adult T-cell leukemia/lymphoma in a patient on hemodialysis-resistance to CHOP, but unexpected effect and remission achieved by sobuzoxane alone]. Gan To Kagaku Ryoho. 2010 Feb;37(2):347–50. 参考文献:10.1007/s12185-010-0511-2 摘要:Nakagawa Y, Miura K, Yamazaki T, Ishizuka H, Takei K, Sawada U, Kura Y, Hatta Y, Takeuchi J. A case of treatment-related myelodysplastic syndrome spontaneously resolved by drug discontinuance. International Journal of Hematology. 2010 Feb 13;91(3):530–3. doi: 10.1007/s12185-010-0511-2. 参考文献:10.1007/s11748-009-0481-6 摘要:Nakano T, Endo S, Tsubochi H, Nokubi M, Watanabe Y, Koyama S. Thymic clear cell carcinoma. General Thoracic and Cardiovascular Surgery. 2010 Feb 13;58(2):98–100. doi: 10.1007/s11748-009-0481-6. 参考文献:10.1007/s12032-010-9446-y 摘要:Ustaalioglu BB, Seker M, Bilici A, Canpolat N, Yıldirim E, Kefeli U, Ustaalioglu R, Yilmaz BE, Salepci T, Ozdemir N, Gumus M. The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma. Med Oncol. 2011 Mar;28(1):258–64. doi: 10.1007/s12032-010-9446-y. 参考文献:10.1007/s00423-010-0599-0 摘要:Romics L, Oláh A, Belágyi T, Hajdú N, Gyurus P, Ruszinkó V. Solid pseudopapillary neoplasm of the pancreas--proposed algorithms for diagnosis and surgical treatment. Langenbecks Arch Surg. 2010 Aug;395(6):747–55. doi: 10.1007/s00423-010-0599-0.